Entrada Therapeutics (TRDA) Price to FCF (2023)
Entrada Therapeutics' Price to FCF was 3.76 in Q4 2023, down 20.6% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Price to FCF (2023) Analysis & Trends
From Q1 2023 onward, Entrada Therapeutics has reported Price to FCF for 4 quarters.
- Per Business Quant data, TRDA's Price to FCF in the three quarters before Q4 2023 was 4.74 (Q3 2023), 4.62 (Q2 2023) and 3.79 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Entrada Therapeutics | 205.54 Mn | -172.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 3.76 |
| Sep 30, 2023 | 4.74 |
| Jun 30, 2023 | 4.62 |
| Mar 31, 2023 | 3.79 |
API Access
Entrada Therapeutics Price to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-fcf&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-fcf", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-fcf&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();